OPKO Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by OPKO Health, Inc. on June 24, 2021. The filing reports on two primary events: the termination of a material definitive agreement and the results of the 2021 Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or liquidity figures for the reporting period. The only financial metric disclosed relates to a terminated credit facility:
- Credit Facility: A $100 million unsecured line of credit was terminated. The company had never drawn on this facility.
- Debt: No outstanding debt was incurred under the terminated agreement.
Material Changes
Termination of Credit Agreement: The Company terminated a Credit Agreement dated February 25, 2020, with an affiliate of Chairman and CEO Dr. Phillip Frost. The termination was subject to the payment of accrued and unpaid commitment fees. As the line of credit was never utilized, this action does not alter the Company's current debt load but removes a committed funding source.
Corporate Governance and Voting Results
The 2021 Annual Meeting of Stockholders concluded with the following outcomes:
- Election of Directors: All twelve nominees were elected to the Board of Directors. Votes were cast for each nominee, with varying levels of "Withheld" votes and "Broker Non-Votes."
- Executive Compensation: Stockholders approved, on a non-binding advisory basis, the compensation of named executive officers. The vote was approximately 94.8% in favor (407.4 million votes for vs. 22.5 million against).
- Appointment of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021. The vote was overwhelmingly in favor (538.3 million votes for vs. 4.6 million against).
Investor Verification Checklist
- Verify the specific amount of accrued and unpaid commitment fees paid to terminate the $100 million credit facility.
- Review the 2021 Proxy Statement for detailed breakdowns of executive compensation referenced in the advisory vote.
- Confirm the Company's current liquidity position and alternative funding sources following the termination of the Frost affiliate credit line.
- Check subsequent filings for any new credit agreements or financing activities replacing the terminated facility.